Prophylactic Donor Lymphocyte Infusion (DLI) Followed by Minimal Residual Disease and Graft-versus-Host Disease–Guided Multiple DLIs Could Improve Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Refractory/Relapsed Acute Leukemia
2017 ◽
Vol 23
(8)
◽
pp. 1311-1319
◽
2020 ◽
Vol 26
(1)
◽
pp. 214
2019 ◽
Vol 25
(5)
◽
pp. 912-920
◽
2020 ◽
Vol 26
(1)
◽
pp. 215
2017 ◽
Vol 23
(8)
◽
pp. 1303-1310
◽